News - BioPharm International



EMA Warns of Falsified Herceptin Vials

April 16, 2014

EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.

American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform

April 11, 2014

Biotechnology developer American CryoStem and Rutgers University partner on stem-cell platform technology development.

PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth

April 11, 2014

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

Center for Biologics Evaluation and Research Relocates

April 11, 2014

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines

April 10, 2014

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Merck Announes Management Changes

April 7, 2014

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

Sun Pharma to Acquire Ranbaxy

April 7, 2014

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

Baxter to Split Into Biopharmaceuticals and Medical Products Companies

March 27, 2014

Baxter announces plans to split into two independent companies by mid-2015.

Pfizer Receives Breakthrough Therapy Designation for Meningococcal B Vaccine Candidate

March 26, 2014

Pfizer intends to submit a biologics license application for its investigational Meningococcal B vaccine candidate, Bivalent rlp2086, to FDA by mid-2014.



Click here